Edgewise Therapeutics, Inc. (EWTX)
39.32
-0.25
(-0.63%)
USD |
NASDAQ |
Oct 08, 16:00
39.32
0.00 (0.00%)
After-Hours: 16:08
Edgewise Therapeutics Net Income (Quarterly) : -57.33M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -57.33M |
| March 31, 2026 | -49.01M |
| December 31, 2025 | -50.22M |
| September 30, 2025 | -40.67M |
| June 30, 2025 | -36.12M |
| March 31, 2025 | -40.80M |
| December 31, 2024 | -39.66M |
| September 30, 2024 | -34.13M |
| June 30, 2024 | -31.50M |
| March 31, 2024 | -28.52M |
| December 31, 2023 | -30.14M |
| September 30, 2023 | -25.71M |
| June 30, 2023 | -21.47M |
| Date | Value |
|---|---|
| March 31, 2023 | -22.84M |
| December 31, 2022 | -19.42M |
| September 30, 2022 | -17.50M |
| June 30, 2022 | -16.07M |
| March 31, 2022 | -14.66M |
| December 31, 2021 | -12.70M |
| September 30, 2021 | -12.95M |
| June 30, 2021 | -10.35M |
| March 31, 2021 | -6.815M |
| December 31, 2020 | -6.342M |
| September 30, 2020 | -3.642M |
| June 30, 2020 | -3.954M |
| March 31, 2020 | -3.185M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | 169.40M |
| Fulcrum Therapeutics, Inc. | -26.18M |
| Definium Therapeutics, Inc. | -158.99M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 57.33M |
| EPS Diluted (Quarterly) | -0.5324 |
| Enterprise Value | 3.808B |
| Earnings Yield | -4.70% |
| Normalized Earnings Yield | -4.703 |